Study #2011-0875
A phase II trial to determine local control and neurocognitive preservation after initial treatment with stereotactic radiosurgery (SRS) for patients with >3 melanoma brain metastases
MD Anderson Study Status
Not Accepting
Treatment Agent
Description
This phase II trial studies how well stereotactic radiosurgery works in treating patients with melanoma that has spread to more than 3 places in the brain. Stereotactic radiosurgery is a specialized radiation therapy that delivers a single, high dose of radiation directly to the tumor and may cause less damage to normal tissue.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Clinical Stage IV Cutaneous Melanoma AJCC v8;Metastatic Malignant Neoplasm in the Brain;Metastatic Melanoma;Pathologic Stage IV Cutaneous Melanoma AJCC v8
Study phase:
Phase II
Physician name:
Jing Li
Department:
Radiation Oncology
For general questions about clinical trials:
1-833-945-1429
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.